A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298 | Zendy

Timothy Wilkin | Zendy; Huichao Chen | Zendy; Michelle Cespedes | Zendy; Jorge Leon-Cruz | Zendy; Catherine Godfrey | Zendy; Elizabeth Y. Chiao | Zendy; Barbara Bastow | Zendy; Jennifer WebsterCyriaque | Zendy; Qinghua Feng | Zendy; Joan Dragavon | Zendy; Robert W. Coombs | Zendy; Rachel M. Presti | Zendy; Alfred J. Saah | Zendy; Ross Cranston | Zendy

Open Access

A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298

Author(s) -

Timothy Wilkin,

Huichao Chen,

Michelle Cespedes,

Jorge Leon-Cruz,

Catherine Godfrey,

Elizabeth Y. Chiao,

Barbara Bastow,

Jennifer WebsterCyriaque,

Qinghua Feng,

Joan Dragavon,

Robert W. Coombs,

Rachel M. Presti,

Alfred J. Saah,

Ross Cranston

Publication year - 2018

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciy274

Subject(s) - medicine , clinical trial , placebo , randomized controlled trial , human papillomavirus , human immunodeficiency virus (hiv) , human papillomavirus vaccine , virology , immunology , pediatrics , cancer , cervical cancer , pathology , gardasil , alternative medicine

Adults living with human immunodeficiency virus (HIV) are at increased risk for anal and oropharyngeal cancer caused by human papillomavirus (HPV). The efficacy of HPV vaccines in this population is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research